111In-Octreotide Scintigraphy for Identification of Metastatic Medullary Thyroid Carcinoma in Children and Adolescents | Zendy

Maya Lodish | Zendy; Urania Dagalakis | Zendy; Clara C. Chen | Zendy; Ninet Sinaii | Zendy; Patricia Whitcomb | Zendy; Alberta Aikin | Zendy; Eva Dombi | Zendy; Leigh Marcus | Zendy; Brigitte C. Widemann | Zendy; Elizabeth Fox | Zendy; Meredith K. Chuk | Zendy; Frank M. Balis | Zendy; Samuel A. Wells | Zendy; Constantine A. Stratakis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

¹¹¹In-Octreotide Scintigraphy for Identification of Metastatic Medullary Thyroid Carcinoma in Children and Adolescents

Author(s) -

Maya Lodish,

Urania Dagalakis,

Clara C. Chen,

Ninet Sinaii,

Patricia Whitcomb,

Alberta Aikin,

Eva Dombi,

Leigh Marcus,

Brigitte C. Widemann,

Elizabeth Fox,

Meredith K. Chuk,

Frank M. Balis,

Samuel A. Wells,

Constantine A. Stratakis

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-2766

Subject(s) - medicine , somatostatin receptor , magnetic resonance imaging , radiology , thyroid carcinoma , abdomen , scintigraphy , octreotide , medullary thyroid cancer , nuclear medicine , thyroid , somatostatin

Most medullary thyroid cancers (MTC) express somatostatin receptors; therefore, (111)In-octreotide somatostatin receptor scintigraphy (SRS) may be useful in detecting sites of metastases in children with MTC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research